Skip to main content
SpringerLink
Log in

Bioabsorbable Endovascular Stent Prostheses

  • Chapter
Coronary Stents

Abstract

Atherosclerotic cardiovascular disease remains the leading cause of death in industrialized countries. Medical treatment has been largely unsuccessful in altering its course. Surgery is an effective treatment in selected cases but carries with it significant morbidity. Percutaneous balloon angioplasty has been developed as an alternative treatment. Since its introduction by Dotter [1] in peripheral arteries, and Grüntzig [2] in coronary arteries, angioplasty has seen a dramatic rise in popularity. In the USA alone, over 200000 coronary angioplasties will be performed in 1990 [3]. However, the success of PTCA has been limited by two major complications: acute vessel closure and late restenosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dotter CT (1969) Transluminally-placed coilspring endarterial tube grafts: long-term patency in canine popliteal artery. Invest Radiol 4:327–332

    Article  Google Scholar 

  2. Grüntzig AR, Senning A, Siegenthaler WE (1979) Nonoperative dilation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301:61–68

    Article  PubMed  Google Scholar 

  3. Ellis SG, Topol EJ (1989) Intracoronary stents: will they fulfill their promise as an adjunct to angioplasty? J Am Coll Cardiol 13:1425–1430

    Article  PubMed  CAS  Google Scholar 

  4. Block PC (1984) Mechanism of transluminal angioplasty. Am J Cardiol 53:69C-72C

    Article  PubMed  CAS  Google Scholar 

  5. Cowley MJ, Dorros G, Kelsey, van Roden K, Detre KM (1984) Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 53:12C-16C

    Article  PubMed  CAS  Google Scholar 

  6. Bredlau CE, Roubin GS, Leimgruber PP et al. (1985) In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 72: 1044–1052

    Article  PubMed  CAS  Google Scholar 

  7. Detre K, Holubkov R, Kelsey S et al. (1988) Percutaneous transluminal coronary angioplasty in 1985–86 and 1977–81. N Engl J Med 318:265–270

    Article  PubMed  CAS  Google Scholar 

  8. McBride W, Lange RA, Hillis DL (1988) Restenosis after successful coronary angioplasty: pathology and prevention. N Engl J Med 318:1734–1737

    Article  PubMed  CAS  Google Scholar 

  9. Ernest SM, Feltz TA, Bal ET et al. (1987) Long term angiographic follow up, cardiac events and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J 57:220–225

    Article  Google Scholar 

  10. Roubin GS, King SB, Douglas JS Jr (1987) Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience. Am J Cardiol 60:39B-44B

    Article  PubMed  CAS  Google Scholar 

  11. Holmes DR Jr, Vliestra RE, Smith HC et al. (1984) Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 53:77C-81C

    Article  PubMed  Google Scholar 

  12. Pepine CJ, Hirshfeld JW, MacDonald RG et al. (1990) A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 81: 1753–1761

    Article  PubMed  CAS  Google Scholar 

  13. Potkin BN, Roberts WC (1988) Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome. Am J Cardiol 62:41

    Article  PubMed  CAS  Google Scholar 

  14. Ip JH, Fuster V, Badimon L et al. (1990) Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle proliferation. J Am Coll Cardiol 15: 1667–1687

    Article  PubMed  CAS  Google Scholar 

  15. Blackshear JL, O’Callaghan WG, Califf RM (1987) Medical approaches to prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 9:834

    Article  PubMed  CAS  Google Scholar 

  16. Webster MW, Chesebro JH, Heras M et al. (1990) Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid artery (abstract). J Am Coll Cardiol 15:165 A

    Article  Google Scholar 

  17. Meier B, Gruentzig AR, King SB III et al. (1984) Higher balloon dilatation pressure in coronary angioplasty. Am Heart J 107:619–622

    Article  PubMed  CAS  Google Scholar 

  18. Quigley PJ, Kereiakes DJ, Abbottsmith CW et al. (1989) Prolonged autoperfusion angioplasty: immediate clinical outcome and angiographic follow-up (abstract). J Am Coll Cardiol 13:155A

    Google Scholar 

  19. Jenkins RD, Safian RD, Dear WE et al. (1990) Laser balloon angioplasty for unstable ischemic syndromes (abstract). J Am Coll Cardiol 15:245A

    Google Scholar 

  20. Hinohara T, Rowe M, Sipperly ME et al. (1990) Restenosis following directional coronary atherectomy of native coronary arteries (abstract). J Am Coll Cardiol 15:196A

    Google Scholar 

  21. Rogers PJ, Garratt KN, Kaufmann UP et al. (1990) Restenosis after atherectomy versus PTCA: initial experience (abstract). J Am Coll Cardiol 15:197A

    Google Scholar 

  22. Ghazzal ZM, Ba’albaki HA, Sewell CW (1990) Restenosis following coronary atherectomy; angiographic follow-up and pathologic correlates (abstract). J Am Coll Cardiol 15:57A

    Google Scholar 

  23. Sketch MH Jr, O’Neill WW, Tcheng JE et al. (1990) Early and late outcome following coronary transluminal extraction-endarterectomy: a multicenter experience (abstract). Circulation 82 [Suppl III]:III-310

    Google Scholar 

  24. Thornton MA, Gruentzig AR, Hollman J et al. (1984) Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 69:721–727

    Article  PubMed  CAS  Google Scholar 

  25. White CW, Knudson M, Schmidt D et al. (1987) Ticlopidine Study Group: neither ticlopidine nor aspirin-dipyridamole prevents restenosis post PTCA: results from a randomized placebo-controlled multicenter trial (abstract). Circulation 76 [Suppl IV]: IV-213

    Google Scholar 

  26. Mufson L, Black A, Roubin G et al. (1988) A randomized trial of aspirin in PTCA: effect of high vs low dose aspirin on major complications and restenosis (abstract). J Am Coll Cardiol 11:236A

    Google Scholar 

  27. Schanzenbacher P, Grimmer M, Maisch B, Kochsiek K (1988) Effect of high dose and low dose aspirin on restenosis after primary successful angioplasty (abstract). Circulation 78 [Suppl II]:II-99

    Google Scholar 

  28. Slack OD, van Tassel J, Orr CM et al. (1987) Can fish oil supplement minimize restenosis after percutaneous transluminal coronary angioplasty? (abstract). J Am Coll Cardiol 9:64A

    Google Scholar 

  29. Milner MR, Gallino RA, Leffingwell A et al. (1988) High kose Omega-3 fatty acid supplementation reduces clinical restenosis after coronary angioplasty (abstract). Circulation 78:11–634

    Google Scholar 

  30. Grigg LE, Kay TW, Valentine PA et al. (1989) Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 13:665–672

    Article  PubMed  CAS  Google Scholar 

  31. Reis GS, Sipperly ME, Boucher TM et al. (1988) Results of a randomized double-blind placebo-controlled trial of fish oil for prevention of restenosis after PTCA (abstract). Circulation 78 [Suppl II]:II-291

    Google Scholar 

  32. Corcos T, David PR, Val PG et al. (1985) Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 109:926–931

    Article  PubMed  CAS  Google Scholar 

  33. Whitworth HB, Roubin GS, Hollman J et al. (1986) Effect of nidedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 8:1271–1276

    Article  PubMed  CAS  Google Scholar 

  34. Klein W, Eber B, Fluch N, Dusleag J (1989) Ketanserin prevents acute occlusion but not restenosis after PTCA (abstract). J Am Coll Cardiol 13:44A

    Google Scholar 

  35. Ellis SG, Roubin GS, Wilentz J et al. (1989) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 117:777–782

    Article  PubMed  CAS  Google Scholar 

  36. Sigwart U, Urban P, Golf S et al. (1988) Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 78:1121–1127

    Article  PubMed  CAS  Google Scholar 

  37. Intracoronary stenting for acute closure following percutaneous transluminal angioplasty (PTCA) (1988) (abstract). Circulation 78 [Suppl II]:II-407

    Google Scholar 

  38. Sigwart U, Kaufman U, Goy J et al. (1988) Prevention of coronary restenosis by stenting. Eur Heart J 9 [Suppl C]:31–37

    PubMed  Google Scholar 

  39. Puel J, Juilliere Y, Bertrand ME et al. (1988) Early and late assessment of stenosis geometry after coronary arterial stenting. Am J Cardiol 61:546–563

    Article  PubMed  CAS  Google Scholar 

  40. Serruys PW, Juilliere Y, Bertrand ME et al. (1988) Additional improvement of stenosis geometry in human coronary arteries by stenting after balloon dilatation. Am J Cardiol 61:71G-76G

    Article  PubMed  CAS  Google Scholar 

  41. Palmaz JC, Windeler SA, Garcia F et al. (1986) Balloon expandable intraluminal grafting of atherosclerotic rabbit aortas. Radiology 160:723–726

    PubMed  CAS  Google Scholar 

  42. Stack RS, Califf RM, Phillips A et al. (1988) Interventional cardiac catheterization at Duke Medical Center: new interventional technology. Am J Cardiol [Suppl F, part II]:3F-24F

    Google Scholar 

  43. King SB III (1989) Vascular stents and atherosclerosis. Circulation 79:460–462

    Article  PubMed  Google Scholar 

  44. Ellis SG, Savage M, Bairn D et al. (1990) Intracoronary stenting to prevent restenosis: preliminary results of a multicenter study using the Palmaz-Schatz stent suggest benefit in selected high risk patients (abstract). J Am Coll Cardiol 15 [Suppl A]:118A

    Google Scholar 

  45. Ellis SG (1990) The Palmaz-Schatz stent: potential coronary applications. In: Topol EJ (ed) Textbook of interventional cardiology. Saunders, Philadelphia, pp 623–632

    Google Scholar 

  46. Fajadet JC, Marco J, Cassagneau BG et al. (1990) Balloon expandable intracoronary stents: analysis of complications in a consecutive series of 160 patients (abstract). Circulation 82 [Suppl III]:III-539

    Google Scholar 

  47. Schatz RA, Palmaz JC, Tio FO et al. (1987) Balloon-expandable intracoronary stents in the adult dog. Circulation 76:450–457

    Article  PubMed  CAS  Google Scholar 

  48. Roubin GS, King SB III, Douglas JS Jr et al. (1990) Intracoronary stenting during percutaneous transluminal coronary angioplasty. Circulation 81 [Suppl IV]:IV-92–100

    Google Scholar 

  49. Hench LL, Ethridge EC (1982) Biomaterials. An interfacial approach. Academic, New York, pp 21–35

    Google Scholar 

  50. Winter GD (1974) Tissue reactions to metallic wear and corrosion products in human patients. J Biomed Mater Res Symp 5:11–26

    Article  Google Scholar 

  51. Sigwart U, Puel J, Mirkovitch V et al. (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701–706

    Article  PubMed  CAS  Google Scholar 

  52. Kulkarni RK, Pani KC, Neuman C et al. (1966) Polylactic acid for surgical implants. Arch Surg 93:839–843

    Article  PubMed  CAS  Google Scholar 

  53. Jamshidi K, Hyon SH, Nakamura T et al. (1986) In vitro and in vivo degradation of poly-L-lactide fibers. In: Christel P et al. (eds) Biological and biomechanical performance of biomaterials. Elsevier, Amsterdam, pp 227–232

    Google Scholar 

  54. Hutchinson FG, Furr BJA (1989) Biodegradable polymers for controlled release of peptides and proteins. In: Roerdink FHD, Kroon AM (eds) Drug carrier systems. John Wiley, New York, pp 111–129

    Google Scholar 

  55. Kulkarni RK, Moore EG, Hefyeli AF, Leonard F (1971) Biodegradable poly(lactic acid) polymers. J Biomed Mater Res 5:169–181

    Article  PubMed  CAS  Google Scholar 

  56. Chapman GD, Gammon RS, Bauman RB et al. (1990) A bioabsorbable stent: initial experimental results (abstract). Circulation 82 [Suppl III]:III-72

    Google Scholar 

  57. Howell ST, Walker WF, Stack RS, Clark HG (1990) Biodegradable intravascular stents: investigation of material properties. 16th annual meeting of the Society of Biomaterials, Charleston, p 29

    Google Scholar 

  58. Dobrin PB (1973) Isometric and isobaric contraction of carotid arterial smooth muscle. Am J Physiol 225:659–663

    PubMed  CAS  Google Scholar 

  59. Cox RH (1975) Arterial wall mechanics and composition and the effects of smooth muscle activation. Am J Physiol 229:807–812

    PubMed  CAS  Google Scholar 

  60. Cavender JB, Anderson P, Roubin GS (1990) The effects of heparin bonded tantalum stents on thrombosis and neointimal proliferation (abstract). Circulation 82 [Suppl III]:III-541

    Google Scholar 

  61. Grunwald J, Haudenschild CC (1984) Intimai injury in vivo activates vascular smooth muscle cell migration and expiant outgrowth in vitro. Arteriosclerosis 4:183–188

    Article  PubMed  CAS  Google Scholar 

  62. Clowes AW, Clowes MM (1986) Kinetics of cellular proliferation after arterial injury. Circ Res 58:839–845

    PubMed  CAS  Google Scholar 

  63. Steele PM, Chesebro JH, Stanson AW et al. (1985) Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 57: 105–112

    PubMed  CAS  Google Scholar 

  64. Chien KR, Knowlton KU (1989) Cardiovascular molecular biology: introduction to the series. Circulation 80:219–233

    Article  PubMed  CAS  Google Scholar 

  65. Swain JL (1989) Gene therapy. A new approach to the treatment of cardiovascular disease. Circulation 80:1495

    Article  PubMed  CAS  Google Scholar 

  66. Dicheck DA, Neville RF, Zwiebel JA et al. (1989) Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 80:1347–1353

    Article  Google Scholar 

  67. Wilson JM, Birinyi LK, Salomon RN et al. (1989) Implantation of vascular grafts lined with genetically modified endothelial cells. Science 244:1344–1346

    Article  PubMed  CAS  Google Scholar 

  68. Nabel EG, Plautz G, Nabel GJ (1990) Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249:1285–1288

    Article  PubMed  CAS  Google Scholar 

  69. Gospodarowicz D Biological activity in vivo and in vitro of pituitary and brain fibroblast growth factor. In: Ford RJ, Maizel AL (eds) Mediators in cell growth and differentiation. Raven, New York, pp 109–134

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interventional Cardiac Catheterization Research Program, Biomedical Engineering Research Department, Duke University Medical Center, Durham, NC, 27710, USA

    R. S. Stack

Authors
  1. R. S. Gammon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. D. Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. P. Bauman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. S. Stack
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Royal Brompton National Heart & Lung Hospitals, Sydney Street, London, SW3 6NP, UK

    Ulrich Sigwart M.D., FACC, FESC

  2. Cardiovascular Program, Northwest Hospital, 1560 North 115th, Suite 206, Seattle, WA, 98133, USA

    George I. Frank M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gammon, R.S., Chapman, G.D., Bauman, R.P., Stack, R.S. (1992). Bioabsorbable Endovascular Stent Prostheses. In: Sigwart, U., Frank, G.I. (eds) Coronary Stents. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76924-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76924-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76926-9

  • Online ISBN: 978-3-642-76924-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation